Delphine Davan 🌎 retweetledi

Last June, our lead asset (MDNA55 or bizaxofusp) was featured on the cover page of #NeuroOncologyJournal. In this Phase 2b study in patients with rec. #glioblastoma, MDNA55 has doubled the mOS compared to SOC. All details in this #publication: ncbi.nlm.nih.gov/pmc/articles/P…

English






